| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |